BioMarin Pharmaceutical Inc. revenue breakdown overview

BioMarin Pharmaceutical Inc. revenue for the last year amounted to 2.42 B USD, the most of which — 2.42 B USD — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 2.10 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought BioMarin Pharmaceutical Inc. 771.31 M USD, and the year before that — 684.28 M USD.